Amsterdam. Biologika haben die Therapie beim schweren Asthma umgekrempelt. Bei den 5 bis 10 Prozent der Asthma-Patienten, die ein schweres Asthma haben, seien orale Steroide heute in den allermeisten ...
Schlucken, Atmen. Das will gut koordiniert sein, und zwar nicht minder effizient als das Ausatmen – Knopf Drücken – Einatmen bei der Nutzung von Inhalations-Devices oder Atemmanöver bei der ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2026 GOLD report newly highlights disease activity ...
Earwax (cerumen) protects the inside of your ears from irritation and infection. As the body makes new wax, the old earwax usually drains out of your ears naturally. Sometimes earwax can build up and ...
Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the Regeneron-partnered drug failed one of a pair of phase 3 chronic obstructive pulmonary ...
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Mepolizumab targets IL-5, addressing eosinophilic inflammation in 20%-40% of COPD patients, marking its fifth US indication. The phase 3 MATINEE trial showed a 21% reduction in annualized moderate or ...
California Legislators endorse bitcoin nonprofit founder Dom Bei for a seat on the $500 billion CalPERS pension board. California Legislators have endorsed bitcoin nonprofit founder Dom Bei in his ...
Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...
Scientists in Japan have demonstrated a new method to create hydrogen fuel without emitting greenhouse gases. But key steps to improve its efficiency remain for it to be commercially viable. When you ...
Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback